The game-changing impact of personalized medicine on pharma supply chain management

In today's era of scientific breakthroughs and technological advancements, personalized medicine can detect the onset of disease at the early stages, pre-empt the progression of the disease

Inflation Spurs Pharmaceuticals To Focus On Sustainability

Inflation rate has reached an all-time high, providing CDMOs with a window of chance to make investments in possibly less expensive, more sustainable choices.

US Healthcare Saves $21 Billion From Biosimilar Rivalry

As per recent Amgen analysis, US market for biosimilars enjoyed rapid growth in 2022, primarily for therapies that tackle inflammatory, oncological conditions.

FDA Searching For Ways To Support Customised Gene Therapy

Academic research teams may find it easier to bring their cures to market with the government guide for developing and producing certain bespoke gene therapies.

Merck-Moderna Sign Cancer Vaccine Deal Worth $250 Million

The option held by Merck and Moderna to co-develop and market a cancer vaccine, mRNA-4157/V940 for a combined sum of $250 million has been exercised by Merck.

Pfizer And Moderna Omicron Kid Boosters Approved By FDA

Pfizer vaccine is now approved for use in children 5 years of age and older, while Moderna vaccination will not be available to kids until they are 6 years old.